{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:03:46Z","timestamp":1790193826518,"version":"4.1.0"},"reference-count":166,"publisher":"European Respiratory Society (ERS)","issue":"161","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2021,6,5]]},"published-print":{"date-parts":[[2021,9,30]]},"abstract":"<jats:p>Acute respiratory distress syndrome (ARDS) is a serious complication of severe systemic or local pulmonary inflammation, such as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ARDS is characterised by diffuse alveolar damage that leads to protein-rich pulmonary oedema, local alveolar hypoventilation and atelectasis. Inadequate perfusion of these areas is the main cause of hypoxaemia in ARDS. High perfusion in relation to ventilation (V\/Q&lt;1) and shunting (V\/Q=0) is not only caused by impaired hypoxic pulmonary vasoconstriction but also redistribution of perfusion from obstructed lung vessels. Rebalancing the pulmonary vascular tone is a therapeutic challenge. Previous clinical trials on inhaled vasodilators (nitric oxide and prostacyclin) to enhance perfusion to high V\/Q areas showed beneficial effects on hypoxaemia but not on mortality. However, specific patient populations with pulmonary hypertension may profit from treatment with inhaled vasodilators. Novel treatment targets to decrease perfusion in low V\/Q areas include epoxyeicosatrienoic acids and specific leukotriene receptors. Still, lung protective ventilation and prone positioning are the best available standard of care. This review focuses on disturbed perfusion in ARDS and aims to provide basic scientists and clinicians with an overview of the vascular alterations and mechanisms of V\/Q mismatch, current therapeutic strategies, and experimental approaches.<\/jats:p>","DOI":"10.1183\/16000617.0059-2021","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T05:45:50Z","timestamp":1631684750000},"page":"210059","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome"],"prefix":"10.1183","volume":"30","author":[{"given":"Mareike","family":"Gierhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Walmrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1946-0894","authenticated-orcid":false,"given":"Werner","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Grimminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2029-4419","authenticated-orcid":false,"given":"Hossein A.","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Weissmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"2024102403563333000_30.161.210059.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(67)90168-7"},{"key":"2024102403563333000_30.161.210059.2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2024102403563333000_30.161.210059.3","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-014-0028-6"},{"key":"2024102403563333000_30.161.210059.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669"},{"key":"2024102403563333000_30.161.210059.5","first-page":"96","article-title":"Adjunctive pharmacotherapy for acute respiratory distress syndrome","volume":"142","author":"Hecker","year":"2017","journal-title":"Dtsch Med Wochenschr"},{"key":"2024102403563333000_30.161.210059.6","doi-asserted-by":"publisher","DOI":"10.1186\/cc9324"},{"key":"2024102403563333000_30.161.210059.7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00037014"},{"key":"2024102403563333000_30.161.210059.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201610-2156SO"},{"key":"2024102403563333000_30.161.210059.9","first-page":"1039","article-title":"Ventilation-perfusion distributions in the adult respiratory distress syndrome","volume":"120","author":"Dantzker","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"2024102403563333000_30.161.210059.10","first-page":"54","article-title":"Distribution of ventilation and perfusion during positive end-expiratory pressure in the adult respiratory distress syndrome","volume":"131","author":"Ralph","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2024102403563333000_30.161.210059.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2011.02048.x"},{"key":"2024102403563333000_30.161.210059.12","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1213\/ANE.0000000000002786","article-title":"Evaluation of almitrine infusion during veno-venous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome in adults","volume":"129","author":"Esnault","year":"2019","journal-title":"Anesth Analg"},{"key":"2024102403563333000_30.161.210059.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00945-2015"},{"key":"2024102403563333000_30.161.210059.14","first-page":"1543","article-title":"Hypoxic pulmonary vasoconstriction in dogs: effects of lung segment size and oxygen tension","volume":"51","author":"Marshall","year":"1981","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"2024102403563333000_30.161.210059.15","doi-asserted-by":"publisher","DOI":"10.1186\/cc1400"},{"key":"2024102403563333000_30.161.210059.16","doi-asserted-by":"publisher","DOI":"10.1007\/BF01720916"},{"key":"2024102403563333000_30.161.210059.17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13613-015-0046-z","article-title":"Echocardiographic detection of transpulmonary bubble transit during acute respiratory distress syndrome","volume":"5","author":"Boissier","year":"2015","journal-title":"Ann Intensive Care"},{"key":"2024102403563333000_30.161.210059.18","doi-asserted-by":"publisher","DOI":"10.1177\/0192623315598399"},{"key":"2024102403563333000_30.161.210059.19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI110281","article-title":"Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs","volume":"68","author":"Hales","year":"1981","journal-title":"J Clin Invest"},{"key":"2024102403563333000_30.161.210059.20","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00355.2011"},{"key":"2024102403563333000_30.161.210059.21","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00120102"},{"key":"2024102403563333000_30.161.210059.22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.006977"},{"key":"2024102403563333000_30.161.210059.23","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00041.2010"},{"key":"2024102403563333000_30.161.210059.24","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1152\/japplphysiol.00120.2017","article-title":"The endothelium in hypoxic pulmonary vasoconstriction","volume":"123","author":"Grimmer","year":"2017","journal-title":"J Appl Physiol"},{"key":"2024102403563333000_30.161.210059.25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1152\/japplphysiol.00103.2017","article-title":"Recent advances in oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction","volume":"123","author":"Strielkov","year":"2017","journal-title":"J Appl Physiol"},{"key":"2024102403563333000_30.161.210059.26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba0694"},{"key":"2024102403563333000_30.161.210059.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1294OC"},{"key":"2024102403563333000_30.161.210059.28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.310482"},{"key":"2024102403563333000_30.161.210059.29","first-page":"1119","article-title":"Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells","volume":"37","author":"Michelakis","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"2024102403563333000_30.161.210059.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.07.035"},{"key":"2024102403563333000_30.161.210059.31","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000281897.13703.fd"},{"key":"2024102403563333000_30.161.210059.32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12931-018-0735-x","article-title":"Role of ATP-sensitive potassium channels on hypoxic pulmonary vasoconstriction in endotoxemia","volume":"19","author":"Turzo","year":"2018","journal-title":"Respir Res"},{"key":"2024102403563333000_30.161.210059.33","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000206114.19707.7C"},{"key":"2024102403563333000_30.161.210059.34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0005-2728(89)80339-1","article-title":"Almitrine, a new kind of energy-transduction inhibitor acting on mitochondrial ATP synthase","volume":"975","author":"Rigoulet","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"2024102403563333000_30.161.210059.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11024-5"},{"key":"2024102403563333000_30.161.210059.36","doi-asserted-by":"publisher","DOI":"10.1161\/hc2901.093117"},{"key":"2024102403563333000_30.161.210059.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200907-0988OC"},{"key":"2024102403563333000_30.161.210059.38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bjaed\/mkw076","article-title":"Hypoxic pulmonary vasoconstriction","volume":"17","author":"Tarry","year":"2017","journal-title":"BJA Educ"},{"key":"2024102403563333000_30.161.210059.39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.82.4.404"},{"key":"2024102403563333000_30.161.210059.40","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198809010-00151"},{"key":"2024102403563333000_30.161.210059.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302113280605"},{"key":"2024102403563333000_30.161.210059.42","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.3.8630585"},{"key":"2024102403563333000_30.161.210059.43","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198904000-00008"},{"key":"2024102403563333000_30.161.210059.44","doi-asserted-by":"publisher","DOI":"10.1186\/cc9264"},{"key":"2024102403563333000_30.161.210059.45","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00011308"},{"key":"2024102403563333000_30.161.210059.46","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(87)90073-9"},{"key":"2024102403563333000_30.161.210059.47","first-page":"612","article-title":"Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease","volume":"130","author":"Melot","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2024102403563333000_30.161.210059.48","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1164\/ajrccm\/136.5.1232","article-title":"Pulmonary vascular tone improves pulmonary gas exchange in the adult respiratory distress syndrome","volume":"136","author":"Melot","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2024102403563333000_30.161.210059.49","doi-asserted-by":"publisher","DOI":"10.1378\/chest.110.3.698"},{"key":"2024102403563333000_30.161.210059.50","doi-asserted-by":"publisher","DOI":"10.1378\/chest.109.2.424"},{"key":"2024102403563333000_30.161.210059.51","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6363(95)00129-8"},{"key":"2024102403563333000_30.161.210059.52","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000560"},{"key":"2024102403563333000_30.161.210059.53","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.197116"},{"key":"2024102403563333000_30.161.210059.54","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000569"},{"key":"2024102403563333000_30.161.210059.55","doi-asserted-by":"publisher","DOI":"10.1124\/mol.53.2.330"},{"key":"2024102403563333000_30.161.210059.56","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1199OC"},{"key":"2024102403563333000_30.161.210059.57","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.3.9705060"},{"key":"2024102403563333000_30.161.210059.58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1465-9921-13-7","article-title":"Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction","volume":"13","author":"Ketabchi","year":"2012","journal-title":"Respir Res"},{"key":"2024102403563333000_30.161.210059.59","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0330OC"},{"key":"2024102403563333000_30.161.210059.60","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00074.2009"},{"key":"2024102403563333000_30.161.210059.61","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00218-5"},{"key":"2024102403563333000_30.161.210059.62","first-page":"107","article-title":"Selective inhibition of guanylate cyclase prevents impairment of hypoxic pulmonary vasoconstriction in endotoxemic mice","volume":"60","author":"Spohr","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"2024102403563333000_30.161.210059.63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119918"},{"key":"2024102403563333000_30.161.210059.64","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6590"},{"key":"2024102403563333000_30.161.210059.65","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.146381"},{"key":"2024102403563333000_30.161.210059.66","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.6.1632"},{"key":"2024102403563333000_30.161.210059.67","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000105423.06091.8E"},{"key":"2024102403563333000_30.161.210059.68","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2564-x"},{"key":"2024102403563333000_30.161.210059.69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/CCM.0000000000000554","article-title":"Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)","volume":"43","author":"Vincent","year":"2015","journal-title":"Crit Care Med"},{"key":"2024102403563333000_30.161.210059.70","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apha.12749","article-title":"The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension","volume":"219","author":"Kylhammar","year":"2017","journal-title":"Acta Physiol"},{"key":"2024102403563333000_30.161.210059.71","doi-asserted-by":"publisher","DOI":"10.2174\/1874192401004010302"},{"key":"2024102403563333000_30.161.210059.72","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.4.369"},{"key":"2024102403563333000_30.161.210059.73","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/80.1.36"},{"key":"2024102403563333000_30.161.210059.74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00254700","article-title":"Thromboxane and prostacyclin release in adult respiratory distress syndrome","volume":"13","author":"Deby-Dupont","year":"1987","journal-title":"Intensive Care Med"},{"key":"2024102403563333000_30.161.210059.75","first-page":"613","article-title":"Eicosanoids and hypoxic pulmonary vasoconstriction in normal man","volume":"23","author":"Naeije","year":"1987","journal-title":"Bull Eur Physiopathol Respir"},{"key":"2024102403563333000_30.161.210059.76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199703273361303"},{"key":"2024102403563333000_30.161.210059.77","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ajem.2018.05.017","article-title":"The effect of aspirin in preventing the acute respiratory distress syndrome\/acute lung injury: a meta-analysis","volume":"36","author":"Yu","year":"2018","journal-title":"Am J Emerg Med"},{"key":"2024102403563333000_30.161.210059.78","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-112821"},{"key":"2024102403563333000_30.161.210059.79","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00038.2017"},{"key":"2024102403563333000_30.161.210059.80","doi-asserted-by":"crossref","first-page":"e13521","DOI":"10.1111\/apha.13521","article-title":"Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia","volume":"230","author":"Strielkov","year":"2020","journal-title":"Acta Physiol"},{"key":"2024102403563333000_30.161.210059.81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003950"},{"key":"2024102403563333000_30.161.210059.82","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00394.2016"},{"key":"2024102403563333000_30.161.210059.83","doi-asserted-by":"crossref","first-page":"e0160359","DOI":"10.1371\/journal.pone.0160359","article-title":"Effects of a soluble epoxide hydrolase inhibitor on lipopolysaccharide-induced acute lung injury in mice","volume":"11","author":"Tao","year":"2016","journal-title":"PLoS One"},{"key":"2024102403563333000_30.161.210059.84","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.chest.2016.10.058","article-title":"Mechanisms of vascular dysfunction in COPD and effects of a novel soluble epoxide hydrolase inhibitor in smokers","volume":"151","author":"Yang","year":"2017","journal-title":"Chest"},{"key":"2024102403563333000_30.161.210059.85","doi-asserted-by":"crossref","first-page":"L434","DOI":"10.1152\/ajplung.2000.278.3.L434","article-title":"Mechanism of hypoxic pulmonary vasoconstriction involves ET(A) receptor-mediated inhibition of K(ATP) channel","volume":"278","author":"Sato","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102403563333000_30.161.210059.86","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00739.2007"},{"key":"2024102403563333000_30.161.210059.87","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2362.2010.02254.x","article-title":"Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans","volume":"40","author":"Pham","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"2024102403563333000_30.161.210059.88","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.5.1169"},{"key":"2024102403563333000_30.161.210059.89","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00591.2014"},{"key":"2024102403563333000_30.161.210059.90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2220\/biomedres.32.9","article-title":"Time-dependent expression of endothelin-1 in lungs and the effects of TNF-alpha blocking peptide on acute lung injury in an endotoxemic rat model","volume":"32","author":"Jesmin","year":"2011","journal-title":"Biomed Res"},{"key":"2024102403563333000_30.161.210059.91","doi-asserted-by":"publisher","DOI":"10.1007\/s001340000608"},{"key":"2024102403563333000_30.161.210059.92","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00408-014-9602-9","article-title":"Bosentan as rescue treatment in refractory hypoxemia and pulmonary hypertension in a patient with ARDS and H7N9 influenza virus infection","volume":"192","author":"Guo","year":"2014","journal-title":"Lung"},{"key":"2024102403563333000_30.161.210059.93","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006674"},{"key":"2024102403563333000_30.161.210059.94","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.1.9704003"},{"key":"2024102403563333000_30.161.210059.95","doi-asserted-by":"publisher","DOI":"10.1161\/hh0801.089177"},{"key":"2024102403563333000_30.161.210059.96","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/138.3.714"},{"key":"2024102403563333000_30.161.210059.97","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200501-034OC"},{"key":"2024102403563333000_30.161.210059.98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308130110"},{"key":"2024102403563333000_30.161.210059.99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1139\/cjpp-2014-0191","article-title":"Montelukast reduces sepsis-induced lung and renal injury in rats","volume":"92","author":"Khodir","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"2024102403563333000_30.161.210059.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.04.029"},{"key":"2024102403563333000_30.161.210059.101","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301141"},{"key":"2024102403563333000_30.161.210059.102","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-47"},{"key":"2024102403563333000_30.161.210059.103","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-208067"},{"key":"2024102403563333000_30.161.210059.104","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06141-z"},{"key":"2024102403563333000_30.161.210059.105","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00890.2002"},{"key":"2024102403563333000_30.161.210059.106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067886"},{"key":"2024102403563333000_30.161.210059.107","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.90963.2008"},{"key":"2024102403563333000_30.161.210059.108","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13396"},{"key":"2024102403563333000_30.161.210059.109","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199702000-00006"},{"key":"2024102403563333000_30.161.210059.110","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.1.9902084"},{"key":"2024102403563333000_30.161.210059.111","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2018.08.081","article-title":"Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018","volume":"272S","author":"Olsson","year":"2018","journal-title":"Int J Cardiol"},{"key":"2024102403563333000_30.161.210059.112","doi-asserted-by":"publisher","DOI":"10.1002\/path.5471"},{"key":"2024102403563333000_30.161.210059.113","doi-asserted-by":"publisher","DOI":"10.1002\/path.2987"},{"key":"2024102403563333000_30.161.210059.114","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181c03009"},{"key":"2024102403563333000_30.161.210059.115","doi-asserted-by":"publisher","DOI":"10.1378\/chest.91.1.52"},{"key":"2024102403563333000_30.161.210059.116","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/CCM.0b013e31817c911d","article-title":"Captopril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury","volume":"36","author":"Chen","year":"2008","journal-title":"Crit Care Med"},{"key":"2024102403563333000_30.161.210059.117","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e318189017a"},{"key":"2024102403563333000_30.161.210059.118","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1823-x"},{"key":"2024102403563333000_30.161.210059.119","first-page":"A2895","article-title":"ACE inhibitor for lung protection during mechanical ventilation for acute lung injury \u2013 results of the double-blind, placebo controlled, randomised ACEmeVENT pilot study","volume":"195","author":"Wirtz","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403563333000_30.161.210059.120","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202003-0817LE"},{"key":"2024102403563333000_30.161.210059.121","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","article-title":"COVID-19 pneumonia: different respiratory treatments for different phenotypes?","volume":"46","author":"Gattinoni","year":"2020","journal-title":"Intensive Care Med"},{"key":"2024102403563333000_30.161.210059.122","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1038\/s41467-020-18672-6","article-title":"Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia","volume":"11","author":"Herrmann","year":"2020","journal-title":"Nat Commun"},{"key":"2024102403563333000_30.161.210059.123","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13613-020-00726-z","article-title":"Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?","volume":"10","author":"Masi","year":"2020","journal-title":"Ann Intensive Care"},{"key":"2024102403563333000_30.161.210059.124","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"2024102403563333000_30.161.210059.125","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01462-5"},{"key":"2024102403563333000_30.161.210059.126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathol"},{"key":"2024102403563333000_30.161.210059.127","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202004-1412OC"},{"key":"2024102403563333000_30.161.210059.128","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/s41366-020-0640-5","article-title":"Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?","volume":"44","author":"Rebello","year":"2020","journal-title":"Int J Obes"},{"key":"2024102403563333000_30.161.210059.129","doi-asserted-by":"crossref","unstructured":"Singh SK . Human Respiratory Viral Infections. Boca Raton, CRC Press, 2014.","DOI":"10.1201\/b16778"},{"key":"2024102403563333000_30.161.210059.130","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-007-6228-6"},{"key":"2024102403563333000_30.161.210059.131","doi-asserted-by":"crossref","first-page":"L277","DOI":"10.1152\/ajplung.00195.2020","article-title":"Novel insights on the pulmonary vascular consequences of COVID-19","volume":"319","author":"Potus","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102403563333000_30.161.210059.132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218081"},{"key":"2024102403563333000_30.161.210059.133","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41401-020-0430-6","article-title":"Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication","volume":"41","author":"Pang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"2024102403563333000_30.161.210059.134","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21037\/atm.2017.12.07","article-title":"Heart-lung interactions in acute respiratory distress syndrome: pathophysiology, detection and management strategies","volume":"6","author":"Sipmann","year":"2018","journal-title":"Ann Transl Med"},{"key":"2024102403563333000_30.161.210059.135","first-page":"112","article-title":"The pulmonary vascular lesions of the adult respiratory distress syndrome","volume":"112","author":"Tomashefski","year":"1983","journal-title":"Am J Pathol"},{"key":"2024102403563333000_30.161.210059.136","first-page":"887","article-title":"Pulmonary vascular remodeling in adult respiratory distress syndrome","volume":"126","author":"Snow","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"2024102403563333000_30.161.210059.137","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-222","DOI":"10.12688\/f1000research.20576.1","article-title":"Emerging concepts in ventilation-induced lung injury","volume":"9","author":"Madahar","year":"2020","journal-title":"F1000Res"},{"key":"2024102403563333000_30.161.210059.138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214103"},{"key":"2024102403563333000_30.161.210059.139","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1013"},{"key":"2024102403563333000_30.161.210059.140","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200506-899OC"},{"key":"2024102403563333000_30.161.210059.141","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2834-6"},{"key":"2024102403563333000_30.161.210059.142","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.23736\/S0375-9393.18.12328-5","article-title":"Non-ventilatory therapies for acute respiratory distress syndrome","volume":"84","author":"Bourenne","year":"2018","journal-title":"Minerva Anestesiol"},{"key":"2024102403563333000_30.161.210059.143","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024102403563333000_30.161.210059.144","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"2024102403563333000_30.161.210059.145","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17023"},{"key":"2024102403563333000_30.161.210059.146","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1164\/ajrccm.159.2.9806133","article-title":"Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration","volume":"159","author":"Gust","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403563333000_30.161.210059.147","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1152\/jappl.1994.76.1.345","article-title":"Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS","volume":"76","author":"Rovira","year":"1994","journal-title":"J Appl Physiol"},{"key":"2024102403563333000_30.161.210059.148","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-016-1566-0","article-title":"Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study","volume":"20","author":"Ruan","year":"2016","journal-title":"Crit Care"},{"key":"2024102403563333000_30.161.210059.149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.08.007"},{"key":"2024102403563333000_30.161.210059.150","doi-asserted-by":"crossref","first-page":"e0259","DOI":"10.1097\/CCE.0000000000000259","article-title":"Evaluation of the efficacy and safety of inhaled epoprostenol and inhaled nitric oxide for refractory hypoxemia in patients with coronavirus disease 2019","volume":"2","author":"DeGrado","year":"2020","journal-title":"Crit Care Explor"},{"key":"2024102403563333000_30.161.210059.151","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.bja.2020.10.011","article-title":"Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome","volume":"126","author":"Longobardo","year":"2021","journal-title":"Br J Anaesth"},{"key":"2024102403563333000_30.161.210059.152","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.bja.2020.11.006","article-title":"Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia","volume":"126","author":"Garfield","year":"2021","journal-title":"Br J Anaesth"},{"key":"2024102403563333000_30.161.210059.153","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2020.12.008","article-title":"The role of NO in COVID-19 and potential therapeutic strategies","volume":"163","author":"Fang","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"2024102403563333000_30.161.210059.154","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13063-020-4163-0","article-title":"Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study","volume":"21","author":"Haeberle","year":"2020","journal-title":"Trials"},{"key":"2024102403563333000_30.161.210059.155","first-page":"288","article-title":"Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog","volume":"128","author":"Romaldini","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"2024102403563333000_30.161.210059.156","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050051"},{"key":"2024102403563333000_30.161.210059.157","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/ajrccm\/137.5.1062","article-title":"Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome","volume":"137","author":"Reyes","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"2024102403563333000_30.161.210059.158","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1164\/ajrccm.158.6.9804066","article-title":"Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. The NO Almitrine Study Group","volume":"158","author":"Gallart","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403563333000_30.161.210059.159","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/j.jvca.2013.03.019","article-title":"Almitrine fails to improve oxygenation during one-lung ventilation with sevoflurane anesthesia","volume":"28","author":"Bermejo","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2024102403563333000_30.161.210059.160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.resp.2013.06.010","article-title":"Respiratory stimulant drugs in the post-operative setting","volume":"189","author":"Golder","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"2024102403563333000_30.161.210059.161","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.05.013"},{"key":"2024102403563333000_30.161.210059.162","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1097\/CCM.0000000000004711","article-title":"Almitrine infusion in severe acute respiratory syndrome coronavirus 2-induced acute respiratory distress syndrome: a single-center observational study","volume":"49","author":"Caplan","year":"2021","journal-title":"Crit Care Med"},{"key":"2024102403563333000_30.161.210059.163","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0877"},{"key":"2024102403563333000_30.161.210059.164","doi-asserted-by":"crossref","first-page":"295","DOI":"10.21037\/atm.2017.06.66","article-title":"Right heart function during acute respiratory distress syndrome","volume":"5","author":"Repesse","year":"2017","journal-title":"Ann Transl Med"},{"key":"2024102403563333000_30.161.210059.165","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-1754-3"},{"key":"2024102403563333000_30.161.210059.166","doi-asserted-by":"publisher","DOI":"10.1007\/BF01705156"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0059-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:03:44Z","timestamp":1740355424000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0059-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":166,"journal-issue":{"issue":"161","published-online":{"date-parts":[[2021,9,15]]},"published-print":{"date-parts":[[2021,9,30]]}},"alternative-id":["10.1183\/16000617.0059-2021"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0059-2021","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]}}}